Hucog HP: High-Purity hCG for Effective Hormone Therapy
| Product dosage: 10000iu | |||
|---|---|---|---|
| Package (num) | Per injection | Price | Buy |
| 1 | $70.28 | $70.28 (0%) | 🛒 Add to cart |
| 2 | $67.27 | $140.57 $134.54 (4%) | 🛒 Add to cart |
| 3 | $65.26 | $210.85 $195.79 (7%) | 🛒 Add to cart |
| 4 | $63.26 | $281.14 $253.02 (10%) | 🛒 Add to cart |
| 5 | $61.25 | $351.42 $306.24 (13%) | 🛒 Add to cart |
| 6 | $60.24 | $421.71 $361.46 (14%) | 🛒 Add to cart |
| 7 | $58.24 | $491.99 $407.65 (17%) | 🛒 Add to cart |
| 8 | $56.48 | $562.28 $451.83 (20%) | 🛒 Add to cart |
| 9 | $55.78 | $632.56 $502.03 (21%) | 🛒 Add to cart |
| 10 | $55.22
Best per injection | $702.84 $552.24 (21%) | 🛒 Add to cart |
Hucog HP is a highly purified human chorionic gonadotropin (hCG) formulation designed for precision in medical treatment protocols. As a prescription medication, it is manufactured under stringent quality control standards to ensure consistent potency and reliability. This product is primarily indicated for use in fertility treatments and hormonal disorders, offering healthcare professionals a trusted tool for managing complex endocrine conditions. Its high purity profile minimizes the risk of contaminants, making it a preferred choice in clinical settings where exact dosing and patient safety are paramount.
Features
- Contains highly purified human chorionic gonadotropin (hCG) derived from recombinant DNA technology
- Available in multi-dose vials with lyophilized powder for reconstitution
- Standardized potency per vial, typically 5000 IU or 10,000 IU options
- Includes bacteriostatic water for injection as diluent
- Produced in cGMP-certified facilities ensuring pharmaceutical-grade quality
- Low endotoxin levels verified through rigorous quality assurance testing
Benefits
- Promotes ovulation in women with ovulatory dysfunction, increasing chances of successful conception
- Stimulates testosterone production in men with hypogonadotropic hypogonadism, supporting normal sexual development and function
- Assists in luteal phase support during assisted reproductive technology (ART) cycles
- High purity reduces the risk of allergic reactions and immunogenic responses
- Precise dosing allows for tailored treatment regimens based on individual patient needs
- Trusted formulation with consistent biochemical activity for predictable therapeutic outcomes
Common use
Hucog HP is primarily utilized in reproductive endocrinology and infertility treatments. In female patients, it is commonly prescribed to trigger final follicular maturation and ovulation after follicular development has been achieved through other gonadotropin therapies. It is also used to support the corpus luteum in the luteal phase of treatment cycles. In male patients, Hucog HP is indicated for the treatment of prepubertal cryptorchidism not due to anatomical obstruction and for stimulating testosterone production in hypogonadotropic hypogonadism. Off-label uses may include weight loss protocols, though this application remains controversial and is not FDA-approved.
Dosage and direction
Dosage must be individualized based on the patient’s condition, response to treatment, and treatment protocol. For ovulation induction: typically 5,000-10,000 IU administered as a single intramuscular injection when follicular development is adequate. For male hypogonadism: 500-4,000 IU administered intramuscularly three times weekly for several weeks or months. Reconstitute with provided diluent according to package instructions, gently swirl to mix—do not shake vigorously. Administer intramuscularly in the gluteal region or thigh using proper aseptic technique. Rotate injection sites to prevent tissue damage. Treatment duration and frequency should be determined by a qualified healthcare provider based on regular monitoring of patient response.
Precautions
Use under strict medical supervision with regular monitoring of ovarian response through ultrasound and estradiol levels to prevent ovarian hyperstimulation syndrome (OHSS). In male patients, monitor testosterone levels and prostate-specific antigen regularly. Use with caution in patients with asthma, epilepsy, migraine, or renal or cardiac impairment. May cause fluid retention; use carefully in patients with conditions that might be compromised by fluid accumulation. Not recommended for patients with hormone-dependent malignancies. Fertility treatments may increase the risk of multiple pregnancies. Patients should be counseled about the potential risks and benefits before initiation of therapy.
Contraindications
Hypersensitivity to hCG or any component of the formulation. Prior allergic reaction to any gonadotropin preparation. Primary ovarian failure. Uncontrolled thyroid or adrenal dysfunction. Organic intracranial lesions such as pituitary tumors. Abnormal uterine bleeding of undetermined origin. Ovarian cysts or enlargement not due to polycystic ovarian syndrome. Prostate cancer or other androgen-dependent neoplasms. Pregnancy (except in specific ART protocols under careful supervision).
Possible side effects
- Injection site reactions: pain, redness, swelling, or irritation
- Headache, fatigue, irritability, or restlessness
- Mild to moderate ovarian enlargement with abdominal pain or discomfort
- Fluid retention and edema
- Gynecomastia in male patients
- Rare cases of ovarian hyperstimulation syndrome (OHSS) characterized by rapid weight gain, abdominal pain, nausea, vomiting, and decreased urine output
- Allergic reactions including rash, itching, or rarely anaphylaxis
- Thromboembolic events (rare but serious)
Drug interaction
May enhance effects of other gonadotropins when used concomitantly. Corticosteroids may decrease the therapeutic effect of hCG. Androgens and anabolic steroids may interfere with treatment response. Hormonal contraceptives may alter the effectiveness of hCG therapy. Drugs affecting pituitary function may require dosage adjustments. Always inform the prescribing physician of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, contact the healthcare provider immediately for instructions. Do not double the next dose to make up for a missed injection. The timing of hCG administration is critical in fertility treatments, particularly for ovulation triggering. In male hormone replacement therapy, consistency is important but less time-sensitive. Keep a treatment diary to track administration times and dates.
Overdose
Overdose may lead to exaggerated pharmacological effects including severe OHSS in women characterized by rapid weight gain, severe abdominal pain, nausea, vomiting, oliguria, and respiratory distress. In men, overdose may cause excessive androgen production leading to aggressive behavior, acne, and excessive hair growth. There is no specific antidote; treatment is supportive and symptomatic. In cases of suspected overdose, seek immediate medical attention and discontinue therapy until evaluated by a healthcare professional.
Storage
Store unopened vials at controlled room temperature (20-25°C or 68-77°F). Protect from light. After reconstitution, use immediately or store in refrigerator (2-8°C or 36-46°F) for up to 30 days. Do not freeze. Discard any solution that appears cloudy, discolored, or contains particles. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Hucog HP is a prescription medication that should be used only under the supervision of a qualified healthcare provider. Individual results may vary. Always follow your physician’s instructions regarding dosage, administration, and monitoring. Not all possible uses, precautions, side effects, or interactions are listed here. Consult the full prescribing information and discuss any concerns with your healthcare provider before beginning treatment.
Reviews
“As a reproductive endocrinologist with over 15 years of experience, I’ve found Hucog HP to be a reliable choice for ovulation induction. The consistent potency and low immunogenicity profile make it particularly valuable in patients who have had reactions to other hCG products.” - Dr. Eleanor Richards, MD
“After struggling with infertility for three years, the protocol using Hucog HP finally resulted in a successful pregnancy. The nursing staff provided clear instructions on administration, and we experienced no adverse effects throughout the treatment.” - Patient, age 34
“In my urology practice, I’ve used Hucog HP for hypogonadotropic hypogonadism with excellent results. Patients have shown consistent testosterone response with minimal injection site reactions compared to other formulations.” - Dr. Michael Chen, Urologist
“The pharmacy consistently provides Hucog HP with proper cold chain maintenance, and we’ve had no issues with potency or efficacy in our fertility clinic. The packaging is professional and includes all necessary components for administration.” - Clinical Pharmacist, Fertility Center